Funded Startups in Jupiter
Jupiter’s most recent disclosed check is Healing Realty Trust’s $25M Series A (2024-06-18), and it stands out against the rest of the disclosed amounts sho…
Jupiter’s most recent disclosed check is Healing Realty Trust’s $25M Series A (2024-06-18), and it stands out against the rest of the disclosed amounts shown here: the next-largest disclosed rounds are Safety Shot ($11M on 2025-07-21) and Dyadic International ($6M on 2024-03-11), while the remaining disclosed values are much smaller ($200K Poiesis Medical on 2021-05-20 and $80K BioCurity Pharmaceuticals on 2022-04-08). That makes one “large-round” outlier a defining feature of this city snapshot.
The pattern is also clustered in time and heavily sector-skewed: 7 of 11 rows fall between 2022-12-06 and 2024-09-04, and biotechnology appears in 4 of 11 entries (Dyadic International 2024-03-11, Myosin Therapeutics 2023-03-14, BioRestorative Therapies 2022-12-06, BioCurity Pharmaceuticals 2022-04-08). Stage/amount disclosure is uneven, with 5 of 11 rounds marked “undisclosed” and 4 of 11 carrying a blank or “Series Unknown” series label. The rows span 2021-05-20 through 2025-10-10, with the latest entry Scenthound (2025-10-10) showing “undisclosed.”
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed round in the Jupiter list, and how far above the rest is it?
Healing Realty Trust’s $25M (Series A on 2024-06-18) is the top disclosed amount in the 11-row snapshot. It’s followed by $11M for Safety Shot (2025-07-21) and $6M for Dyadic International (2024-03-11), with smaller disclosed rounds including $200K Poiesis Medical (2021-05-20) and $80K BioCurity Pharmaceuticals (2022-04-08).
Do the rounds cluster into a narrow time window rather than being evenly spread?
Yes. Seven of the 11 rows land between 2022-12-06 (BioRestorative Therapies) and 2024-09-04 (Safety Shot), while older disclosed amounts appear only at the edges—$200K on 2021-05-20 and $80K on 2022-04-08.
Is any sector over-represented relative to the others in this Jupiter slice?
Biotechnology is the clear concentration: it appears in 4 of 11 entries (Dyadic International 2024-03-11 at $6M, Myosin Therapeutics 2023-03-14 as “undisclosed,” BioRestorative Therapies 2022-12-06 as “undisclosed,” and BioCurity Pharmaceuticals 2022-04-08 at $80K). Health Care shows up in 3 of 11 entries (Safety Shot twice; Poiesis Medical), while Pets/Wellness, Real Estate, Consumer Services, Financial Services each appear once.
How much of the list lacks series and/or amount disclosure?
Disclosure is incomplete in multiple ways: 5 of 11 amounts are explicitly “undisclosed” (Scenthound 2025-10-10; El Sol 2023-05-19; Myosin Therapeutics 2023-03-14; BioRestorative Therapies 2022-12-06; InsurePay 2022-04-06). On the stage label, 4 of 11 rows show “Series Unknown” or a blank series field (Safety Shot 2025-07-21 and 2024-09-04; El Sol 2023-05-19; Myosin Therapeutics 2023-03-14).
Are there outliers worth prioritizing for outreach, not just largest checks?
Yes, two types stand out. On the high end, the only disclosed round above $10M is Safety Shot’s $11M (2025-07-21), and Healing Realty Trust’s $25M is the dominant outlier among disclosed amounts; on the low end, the smallest disclosed figures are $80K (BioCurity Pharmaceuticals on 2022-04-08) and $200K (Poiesis Medical on 2021-05-20), both far below the mid-single-digit disclosed rounds like Dyadic International’s $6M (2024-03-11).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.